Because regulatory approval of cognitive enhancement drugs is likely, physicians may want to consider whether they would condone the practice for restoration of function only or for enhancement purposes as well.
Taking care of patients whose cultures, belief systems, and family hierarchy structures differ from those on which many U.S. laws and regulations involves strategies—particularly regarding end-of-life care and surrogate decision making.
Taking care of patients whose cultures, belief systems, and family hierarchy structures differ from those on which many U.S. laws and regulations involves strategies—particularly regarding end-of-life care and surrogate decision making.
Physicians who base end-of-life care decisions for patients on their own preferences may offer less treatment than the patients themselves would have wanted.
Ana E. Nunez, MD, Candace J. Robertson, MPH, and Jill A. Foster, MD
The Drexel University College of Medicine Women’s Health Education Program is a model for training medical students to screen for and respond to intimate partner violence.